PATENT CLAIM ANALYSIS

Application Number: 15939495
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "006110"]

Abstract:
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.

Claim (Index 17):
The method of  claim 1 , wherein said antibody or antibody fragment that specifically binds to human PD-L1 is administered by intravenous or subcutaneous injection and/or is comprised in an injectable preparation.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.05263
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14536049', '14659910', '15939503', '14731727', '14868952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7619685782114232
- 35 USC 102 Novelty (BERT): 0.7040983501369827
- Combined Prediction Score: 0.7561815554039791
- Mean Citation Score: 783.1729640000003
- Max Citation Score: 795.2167400000003
- Similarity Product: 745.7362394884124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test